Generic Name MEPOLIZUMAB Review Date Began Sun, 06/19/2022 - 12:00 Review Date Completed Thu, 08/11/2022 - 12:00 Conclusion PDL Product Committee Month Thu, 09/01/2022 - 12:00 Sat, 10/01/2022 - 12:00